These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 31037448)

  • 21. Efficacy of Vonoprazan-Based Triple Therapy for Helicobacter pylori Eradication: A Multicenter Study and a Review of the Literature.
    Tanabe H; Ando K; Sato K; Ito T; Goto M; Sato T; Fujinaga A; Kawamoto T; Utsumi T; Yanagawa N; Ichiishi E; Otake T; Kohgo Y; Nomura Y; Ueno N; Sugano H; Kashima S; Moriichi K; Fujiya M; Okumura T
    Dig Dis Sci; 2017 Nov; 62(11):3069-3076. PubMed ID: 28664410
    [TBL] [Abstract][Full Text] [Related]  

  • 22. What consideration should be given to Helicobacter pylori in treating nonsteroidal anti-inflammatory drug ulcers?
    Hawkey CJ
    Eur J Gastroenterol Hepatol; 2000 Jun; 12 Suppl 1():S17-20. PubMed ID: 10929894
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vonoprazan prevents bleeding from endoscopic submucosal dissection-induced gastric ulcers.
    Kagawa T; Iwamuro M; Ishikawa S; Ishida M; Kuraoka S; Sasaki K; Sakakihara I; Izumikawa K; Yamamoto K; Takahashi S; Tanaka S; Matsuura M; Hasui T; Wato M; Inaba T
    Aliment Pharmacol Ther; 2016 Sep; 44(6):583-91. PubMed ID: 27464849
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vonoprazan, a novel potassium-competitive acid blocker, as a component of first-line and second-line triple therapy for Helicobacter pylori eradication: a phase III, randomised, double-blind study.
    Murakami K; Sakurai Y; Shiino M; Funao N; Nishimura A; Asaka M
    Gut; 2016 Sep; 65(9):1439-46. PubMed ID: 26935876
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of melatonin and tryptophan on healing of gastric and duodenal ulcers with Helicobacter pylori infection in humans.
    Celinski K; Konturek PC; Konturek SJ; Slomka M; Cichoz-Lach H; Brzozowski T; Bielanski W
    J Physiol Pharmacol; 2011 Oct; 62(5):521-6. PubMed ID: 22204799
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endoscopic characteristics and Helicobacter pylori infection in NSAID-associated gastric ulcer.
    Kamada T; Hata J; Kusunoki H; Sugiu K; Tanimoto T; Mihara M; Hamada H; Kido S; Dongmei Q; Haruma K
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):98-102. PubMed ID: 16706819
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Randomised clinical trial: efficacy and safety of vonoprazan vs. lansoprazole in patients with gastric or duodenal ulcers - results from two phase 3, non-inferiority randomised controlled trials.
    Miwa H; Uedo N; Watari J; Mori Y; Sakurai Y; Takanami Y; Nishimura A; Tatsumi T; Sakaki N
    Aliment Pharmacol Ther; 2017 Jan; 45(2):240-252. PubMed ID: 27891632
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of sex and Helicobacter pylori on development and healing of gastroduodenal lesions in non-steroidal anti-inflammatory drug users.
    Hawkey CJ; Wilson I; Naesdal J; Långström G; Swannell AJ; Yeomans ND
    Gut; 2002 Sep; 51(3):344-50. PubMed ID: 12171954
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ulcer-healing drugs are required after eradication of Helicobacter pylori in patients with gastric ulcer but not duodenal ulcer haemorrhage.
    Lai KC; Hui WM; Wong BC; Hu WH; Lam SK
    Aliment Pharmacol Ther; 2000 Aug; 14(8):1071-6. PubMed ID: 10930902
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical and endoscopic characteristics of non-Helicobacter pylori, non-NSAID duodenal ulcers: a long-term prospective study.
    Xia HH; Wong BC; Wong KW; Wong SY; Wong WM; Lai KC; Hu WH; Chan CK; Lam SK
    Aliment Pharmacol Ther; 2001 Dec; 15(12):1875-82. PubMed ID: 11736717
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Randomised trial of eradication of Helicobacter pylori before non-steroidal anti-inflammatory drug therapy to prevent peptic ulcers.
    Chan FK; Sung JJ; Chung SC; To KF; Yung MY; Leung VK; Lee YT; Chan CS; Li EK; Woo J
    Lancet; 1997 Oct; 350(9083):975-9. PubMed ID: 9329511
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The prevalence of peptic ulcer not related to Helicobacter pylori or non-steroidal anti-inflammatory drug use is negligible in southern Europe.
    Arroyo MT; Forne M; de Argila CM; Feu F; Arenas J; de la Vega J; Garrigues V; Mora F; Castro M; Bujanda L; Cosme A; Castiella A; Gisbert JP; Hervas A; Lanas A
    Helicobacter; 2004 Jun; 9(3):249-54. PubMed ID: 15165261
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recurrent peptic ulcers in patients following successful Helicobacter pylori eradication: a multicenter study of 4940 patients.
    Miwa H; Sakaki N; Sugano K; Sekine H; Higuchi K; Uemura N; Kato M; Murakami K; Kato C; Shiotani A; Ohkusa T; Takagi A; Aoyama N; Haruma K; Okazaki K; Kusugami K; Suzuki M; Joh T; Azuma T; Yanaka A; Suzuki H; Hashimoto H; Kawai T; Sugiyama T
    Helicobacter; 2004 Feb; 9(1):9-16. PubMed ID: 15156899
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Short-term efficacy of potassium-competitive acid blocker following gastric endoscopic submucosal dissection: a propensity score analysis.
    Horikawa Y; Mizutamari H; Mimori N; Kato Y; Fushimi S; Sato S; Okubo S
    Scand J Gastroenterol; 2018 Feb; 53(2):243-251. PubMed ID: 29214885
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of Helicobacter pylori infection in duodenal ulcer and gastro-duodenal ulcer diseases in Taiwan.
    Chen TS; Luo JC; Chang FY
    J Gastroenterol Hepatol; 2010 May; 25(5):919-22. PubMed ID: 20074147
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The relative contribution of NSAIDs and Helicobacter pylori to the aetiology of endoscopically-diagnosed peptic ulcer disease: observations from a tertiary referral hospital in the UK between 2005 and 2010.
    Musumba C; Jorgensen A; Sutton L; Van Eker D; Moorcroft J; Hopkins M; Pritchard DM; Pirmohamed M
    Aliment Pharmacol Ther; 2012 Jul; 36(1):48-56. PubMed ID: 22554233
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [What role today for Helicobacter pylori in peptic ulcer?].
    Cadiot G
    Gastroenterol Clin Biol; 2003 Mar; 27(3 Pt 2):409-14. PubMed ID: 12700497
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nonsteroidal anti-inflammatory drug use does not affect short-term endoscopic and histologic outcomes after Helicobacter pylori eradication in patients with rheumatoid arthritis.
    Tanaka E; Kamitsuji S; Inoue E; Yamada T; Nakajima A; Takeuchi E; Yanagisawa A; Misaka R; Shigemoto M; Yamashita K; Imamura T; Hara M; Tomatsu T; Saito T; Lauren G; Triadafilopoulos G; Kamatani N; Singh G; Yamanaka H
    Mod Rheumatol; 2007; 17(3):228-34. PubMed ID: 17564779
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Helicobacter pylori-negative gastric and duodenal ulcers.
    Tsuji H; Kohli Y; Fukumitsu S; Morita K; Kaneko H; Ohkawara T; Minami M; Ueda K; Sawa Y; Matsuzaki H; Morinaga O; Ohkawara Y
    J Gastroenterol; 1999 Aug; 34(4):455-60. PubMed ID: 10452677
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Short-term triple therapy with pantoprazole, clarithromycin and metronidazole for the healing of Helicobacter pylori infection].
    Adamek RJ; Szymanski C; Pfaffenbach B; Opferkuch W; Ricken D; Wegener M
    Dtsch Med Wochenschr; 1995 Mar; 120(11):358-60. PubMed ID: 7889816
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.